How To Transfer Surveillance Oversight For IVDs From One EU Notified Body To Another

With the final deadlines for legacy products that need to comply with the IVD Regulation on the horizon next year, help is at hand to transfer responsibility for surveillance from one notified body to another. But who will need it and why?

Man passing the baton to partner on track against close up of the track starting point - Image
At Some Point, Surveillance Responsibility For IVDs Must Change Hands

Members of the TEAM-NB association of notified bodies have adopted an agreement specifying the terms of the transfer of the appropriate surveillance activities for legacy IVDs from one notified body to another.

Legacy IVDs are products that remain covered by an IVD Directive notified body certificate during the extended transitional periods they...

More from Europe

EUDAMED Notice Anticipated By September As Commission Optimizes Operations

 

The last steps are taking place leading to the launch of the EU’s medical device database, EUDAMED.

FDA Greenlights Expanded Use Of Boston Scientific’s Pulse Field Ablation System

 

A recent approval from the US FDA allowing Boston Scientific to broaden its labeling for its pulse field ablation system means more patients with one type of AFib will have access to a promising new treatment.

Commission Decision Launches Pediatric And Rare Disease Expert Group

 

A revised annex to the original decision also outlines expert remuneration limits and introduces further changes.

Thena Capital’s New Fund Up And Running With £1M Investment In Plexāā’s Breast Cancer Device

 

Thena Capital, the first UK-based early-stage specialist medtech firm, has made its first investment since closing its £50m fund. Medtech Insight spoke with general partner Pamela Walker Geddes to gain insight into Thena Capital’s investment strategy.

More from Geography